2023 annual financial data
Alaunos Therapeutics 2023 Operating margin
Direct answer
Operating margin was -685,340%.
Operating income was -34,267,000 USD and net income was -35,140,000 USD.
Operating cash flow was -30,142,000 USD.
Get free Alaunos Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 5,000 USD
- Operating income
- -34,267,000 USD
- Net income
- -35,140,000 USD
- Operating cash flow
- -30,142,000 USD